NCT01668134

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

Feasibility Study of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Washington University School of Medicine · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is being done to determine if targeted radiation therapy (stereotactic) can be given to treat liver cancer, for patient who are unable to undergo surgery, over a short period of time with a small amount of side effects.

Conditions

• Carcinoma, Hepatocellular
• Intrahepatic Cholangiocarcinoma

Interventions

Type	Name	Description
RADIATION	Stereotactic radiation

Timeline

• Start date: 2009-12-16
• Primary completion: 2014-08-30
• Completion: 2015-12-22
• First posted: 2012-08-17
• Last updated: 2017-02-20

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study